# Imatinib for refractory chronic graft-versus-host disease with fibrotic features

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/imatinib-for-refractory-chronic-graft-versus-host-disease-with-fibrotic-features/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Attilio Olivieri,Franco Locatelli,Marco Zecca,Adele Sanna,Michele Cimminiello,R Raimondi,Guido Gini,Nicola Mordini,Adriana Balduzzi,Pietro Leoni,Armando Gabrielli,Andrea Bacigalupo |
| Citations | 233 |
| DOI | 10.1182/blood-2009-02-204156 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2041548911 |
| PMID | 19403889 |
| Type | article |
| Year | 2009 |

## Paper authors

- [Adriana Balduzzi](https://scholariq.org/researchers/adriana-balduzzi/)

## Paper journal

- [Blood](https://scholariq.org/journals/blood/)

## Paper primary topic

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

## Paper topics

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Eosinophilic Disorders and Syndromes](https://scholariq.org/topics/eosinophilic-disorders-and-syndromes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.